COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 3053: Articles 30521-30530  | Next

Real-time monitoring the transmission potential of COVID-19 in Singapore, February 2020
Tariq, A., Lee, Y., Roosa, K., Blumberg, S., Yan, P., MA, S., Chowell, G.
10.1101/2020.02.21.20026435 — Posted: 2020-02-25
Trends in Transmissibility of 2019 Novel Coronavirus-infected Pneumonia in Wuhan and 29 Provinces in China
Lin, H., Liu, W., Gao, H., Nie, J., Fan, Q.
10.1101/2020.02.21.20026468 — Posted: 2020-02-25
Characterizing the transmission and identifying the control strategy for COVID-19 through epidemiological modeling
Zhang, K. K., Xie, L., Lawless, L., Zhou, H., Gao, G., Xue, C.
10.1101/2020.02.24.20026773 — Posted: 2020-02-25
Intrinsic growth rules of patients infected, dead and cured with 2019 novel coronavirus in mainland China
Han, C., Liu, Y., Yang, S.
10.1101/2020.02.23.20024802 — Posted: 2020-02-25
Estimating the serial interval of the novel coronavirus disease (COVID-19): A statistical analysis using the public data in Hong Kong from January 16 to February 15, 2020
Zhao, S., Gao, D., Zhuang, Z., Chong, M., Cai, Y., Ran, J., Cao, P., Wang, K., Lou, Y., Wang, W., Yang, L., He, D., Wang, M.
10.1101/2020.02.21.20026559 — Posted: 2020-02-25
Lessons learnt from 288 COVID-19 international cases: importations over time, effect of interventions, underdetection of imported cases
Pinotti, F., Di Domenico, L., Ortega, E., Mancastroppa, M., Pullano, G., Valdano, E., Boelle, P.-Y., Poletto, C., Colizza, V.
10.1101/2020.02.24.20027326 — Posted: 2020-02-25
Clinical features and laboratory inspection of novelcoronavirus pneumonia (COVID-19) in Xiangyang, Hubei
Cao, W.
10.1101/2020.02.23.20026963 — Posted: 2020-02-25
Applying chemical reaction transition theory to predict the latent transmission dynamics of coronavirus outbreak in China
Xu, P.
10.1101/2020.02.22.20026815 — Posted: 2020-02-25
Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series
Qian, G.-Q., Yang, N.-B., Ding, F., Ma, A. H. Y., Wang, Z.-Y., Shen, Y.-F., Shi, C.-W., Lian, X., Chu, J.-G., Chen, L., Wang, Z.-Y., Ren, D.-W., Li, G.-X., Chen, X.-Q., Shen, H.-J., Chen, X.-M.
10.1101/2020.02.23.20026856 — Posted: 2020-02-25
A Peptide-based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Corona Virus Disease 2019 (COVID-19)
Cai, X., Chen, J., Hu, J., Long, Q., Deng, H., Fan, K., Liao, P., Liu, B., Wu, G., Chen, Y., Li, Z., Wang, K., Zhang, X., Tian, W., Xiang, J., Du, H., Wang, J., Hu, Y., Tang, N., Lin, Y., Ren, J., Huang, L., Wei, J., Gan, C., Chen, Y., Gao, Q., Chen, A., He, C., Wang, D., Hu, P., Zhou, F., Huang, A., Liu, P., Wang, D.
10.1101/2020.02.22.20026617 — Posted: 2020-02-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).